เอกสารอ้างอิง
[1]. Jacobs DS. Open-angle glaucoma: Epidermiology, clinical presentation, and diagnosis. In: Post TW, ed. UpToDate. Waltham: UpToDate; 2022. (Accessed on January 17, 2022)
[2]. Gedde SJ, Vinod K, Wright MM, Muir KW, Lind JT, Chen PP, et al; American academy of ophthalmology preferred practice pattern glaucoma panel. Primary open-angle glaucoma preferred practice pattern®. Ophthalmology. 2021;128(1):P71-P150.
[3]. Khondkaryan A, Francis BA. Angle-closure glaucoma [internet]. San Francisco, CA: The American Academy of Ophathalmology; 2013 [cited 17 January 2022]. Available from: https://www.aao.org/munnerlyn-laser-surgery-center/angleclosure-glaucoma-19.
[4]. Weizer JS. Angle-closure glaucoma. In: Post TW, ed. UpToDate. Waltham: UpToDate; 2022. (Accessed on January 17, 2022)
[5]. Jacobs DS. Open-angle glaucoma: Treatment. In: Post TW, ed. UpToDate. Waltham: UpToDate; 2022. (Accessed on January 17, 2022)
[6]. Tafluprost. In: Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2021 [updated 16 January 2022; cited 17 January 2022]. Available from: http://online.lexi.com.
[7]. Latanoprost. In: Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2021 [updated 16 January 2022; cited 17 January 2022]. Available from: http://online.lexi.com.
[8]. Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, et al. Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology. 2016;123(1):129-40.
[9]. Kim JM, Park SW, Seong M, Ha SJ, Lee JW, Rho S, et al. Comparison of the safety and efficacy between preserved and preservative-free latanoprost and preservative-free tafluprost. Pharmaceuticals (Basel). 2021;14(6):501.